Landmark clinical evidence shows that the IV tubing end connector (a "male luer" connector) is susceptible to microbial contamination and routinely causes cross-contamination between IV connectors. Studies also confirm that biofilm, which is responsible for the majority of blood stream infections, forms on these connectors and that a contaminated connector will transfer microbes into a patients IV catheter. The Company is now selling the DualCap System, a product family that includes DualCap®, the only FDA-cleared device for disinfection and protection of both the IV catheter needleless luer access valve and the male luer connector.
In addition to DualCap, the system includes two devices: DualCap Duo™ and DualCap Solo™. DualCap Duo is a sterile, single-use device containing two disinfecting caps - both for use on frequently accessed luer access valves. It is the only device with two disinfectant caps for luer access valves conveniently located in one sterile package. DualCap Solo™ is a sterile, single disinfecting cap for use on luer access valves. The DualCap System combines efficacy and simplicity, arming clinicians with a complete set of easy-to-use and safe devices.
IV Catheter-Related Blood Stream Infections
Each year more than 500,000 patients in U.S. hospitals suffer from IV catheter-related blood stream infections and up to one in four patients die. Due to the preventability of these infections, insurers no longer reimburse hospitals for treating them, costing hospitals up to $11 billion annually; hospitals lose an average of $47,000 per infection.
This means that the traditional method of disinfecting IV access valves using an alcohol swab to scrub the valve surface, currently in place at the majority of U.S. hospitals, is insufficient. This method does not disinfect the male luer connector, and even if access valves are scrubbed the variability in scrubbing technique among clinicians leads to inconsistent valve disinfection. The DualCap System is the only integrated solution that addresses these deficiencies.
"We understand the profound sense of personal accountability that clinicians feel about delivering safe care to patients. Because current partial solutions fail, Catheter Connections designed the DualCap System to help healthcare professionals address safety gaps in IV delivery methods and prevent potentially deadly infections. We want to save lives," said Vicki Farrar, Esq., CEO of Catheter Connections. "Many healthcare professionals are unaware that simply disinfecting the access valve of the patients IV catheter is not enough to protect the patient from contamination. The new DualCap System delivers the right devices at the right time for clinicians to make the right choice when managing patients IV lines."
About Catheter Connections
Headquartered in Salt Lake City, Utah, Catheter Connections®, Inc., develops and commercializes innovative vascular access products designed to protect patients from acquiring infections during intravenous infusion therapy. Its DualCap System™ is a family of user-friendly products that provides healthcare facilities with a cost-effective, integrated solution for IV disinfection and protection, helping in the fight against IV catheter-related blood stream infections. Designed by infusion nurses, flagship product DualCap® safely disinfects both IV tubing end connectors and IV catheter access valves - a major breakthrough for infection control. For more information, visit www.catheterconnections.com.